{
    "nctId": "NCT04408560",
    "briefTitle": "Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer",
    "officialTitle": "Evaluation of the Efficacy of a Homeopathic Protocol to Reduce the Onset or Aggravation of Joint Pain or Stiffness Following the Taking of Anti-aromatases (AI) in Patients With Non-metastatic Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Female, Joint Pain",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 140,
    "primaryOutcomeMeasure": "Evolution of the score of \"most intense pain\" during the first 3 months of treatment with AI",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* menopausal patient\n* achieved histologically confirmed non-metastatic breast cancer with positive hormonal receptors\n* starting an adjuvant anti-hormonal treatment with an AI\n* patient benefiting from a social protection scheme\n* patient mastering the French language -signature of free and informed consent -\n\nExclusion Criteria:\n\n* patient whose treatment with chemotherapy or radiotherapy is ongoing or anticipated during the theoretical period of the study or patient who has completed her chemotherapy treatment within a period of less than 4 weeks prior to the inclusion visit\n* patient with proven inflammatory rheumatism already diagnosed with rheumatoid arthritis, lupus, psoriatic rheumatism, ankylosing spondylitis -concomitant treatment with other complementary medicines (excepted Vitamin D), unless the treatment has been stable for at least 1 month.\n* current treatment with narcotic drugs or corticosteroids\n* patient with overexpressing breast cancer HER2",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}